- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06233617
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery
Study Overview
Status
Detailed Description
This study is proposed to explore the effect of perineurial Dexamethasone and Dexmedetomidine on erector spinal plane block duration for spine surgery.
After spine surgery, patients need good analgesia. Peripheral nerve blocks have provided a safe, effective method to control early postoperative pain when symptoms are most severe.
The safety of local anaesthesia is essential due to the much lower toxicity threshold of local anaesthetics. An effective adjuvant, such as Dexamethasone or Dexmedetomidine, could allow for a higher dilution of local anaesthetics while maintaining and enhancing their analgesic effect.
There is considerable research where intravenous and perineural dexamethasone and Dexmedetomidine use have been compared in adults. However, there is a massive lack of research regarding spine surgery and the Erector Spinae Plane Block.
In this study, investigators compare perineural Dexamethasone and Dexmedetomidine.
The investigator aims to find a dexamethasone or dexmedetomidine that covers the need for good pain relief and fast recovery postoperatively.
Study Type
Enrollment (Estimated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Malgorzata Domagalska, PhD
- Phone Number: +48 61 873 83 03
- Email: m.domagalska@icloud.com
Study Contact Backup
- Name: Malgorzata Domagalska, PhD
- Phone Number: 608762068
- Email: m.domagalska@icloud.com
Study Locations
-
-
Poznań
-
Poznan, Poznań, Poland, 61-701
- Poznan University of Medical Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- patients undergoing primary posterior lumbar decompression and stabilization with instrumentation involving multi-levels in the lumbar region,
- aged >18 years and <100 years
- ASA physical status 1, 2 or 3.
Exclusion Criteria:
- refuse to participate,
- history of opioid abuse,
- infection of the puncture site,
- aged <18 years and >100 years
- ASA 4 and 5
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: placebo
0.2% ropivacaine for erector spinae plane block
|
biliteral administration of 20ml of 0,2% ropivacaine + 2ml 0.9% sodium chloride for the erector spine plane block
|
Active Comparator: Dexamethasone
0.2% ropivacaine + 4mg Dexamethasone for erector spinae plane block
|
biliteral administration of 20ml of 0,2% ropivacaine with 4mg Dexamethasone for the erector spine plane block
|
Active Comparator: Dexmedetomidine
0.2% ropivacaine + 50ug Dexmedetomidine for erector spinae plane block
|
biliteral administration of 20ml of 0,2% ropivacaine with 50ug Dexmedetomidine for the erector spine plane block
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
first need of opiate
Time Frame: 48 hours
|
Time after surgery when the patient needs opiate for the first time
|
48 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Opioid consumption
Time Frame: 48 hours
|
Total opiate consumption after surgery
|
48 hours
|
Numerical Rating Scale [range 0:10]
Time Frame: Time Frame: 4 hours after surgery
|
NRS (Numerical Rating Scale; 0 - no pain; 10 - the worst pain ever)
|
Time Frame: 4 hours after surgery
|
Numerical Rating Scale [range 0:10]
Time Frame: Time Frame: 8 hours after surgery
|
NRS (Numerical Rating Scale; 0 - no pain; 10 - the worst pain ever)
|
Time Frame: 8 hours after surgery
|
Numerical Rating Scale [range 0:10]
Time Frame: Time Frame: 12 hours after surgery
|
NRS (Numerical Rating Scale; 0 - no pain; 10 - the worst pain ever)
|
Time Frame: 12 hours after surgery
|
Numerical Rating Scale [range 0:10]
Time Frame: Time Frame: 16 hours after surgery
|
NRS (Numerical Rating Scale; 0 - no pain; 10 - the worst pain ever)
|
Time Frame: 16 hours after surgery
|
Numerical Rating Scale [range 0:10]
Time Frame: Time Frame: 20 hours after surgery
|
NRS (Numerical Rating Scale; 0 - no pain; 10 - the worst pain ever)
|
Time Frame: 20 hours after surgery
|
Numerical Rating Scale [range 0:10]
Time Frame: Time Frame: 24 hours after surgery
|
NRS (Numerical Rating Scale; 0 - no pain; 10 - the worst pain ever)
|
Time Frame: 24 hours after surgery
|
NLR
Time Frame: 48 hours after surgery
|
Neutrophil-to-lymphocyte ratio
|
48 hours after surgery
|
PLR
Time Frame: 48 hours after surgery
|
Platelet-to-lymphocyte ratio
|
48 hours after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Malgorzata Domagalska, PhD, Poznan University of Medical Sciences
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Musculoskeletal Diseases
- Bone Diseases
- Spinal Diseases
- Spinal Stenosis
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Autonomic Agents
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Antiemetics
- Gastrointestinal Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Antineoplastic Agents, Hormonal
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Hypnotics and Sedatives
- Dexamethasone
- Dexmedetomidine
Other Study ID Numbers
- 3/2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Stenosis
-
RTI SurgicalCompletedSpinal Disease | Spinal Instability | Spinal Stenosis Occipito-Atlanto-Axial | Spinal Stenosis Cervical | Spinal Stenosis Cervicothoracic RegionUnited States
-
Sutherland Medical CenterActive, not recruitingSpinal Stenosis Lumbar | Spinal Canal StenosisPoland
-
Massachusetts General HospitalCompletedLumbar Spinal Stenosis | Thoracic Spinal StenosisUnited States
-
Azienda Usl di BolognaRecruitingLumbar Spinal Stenosis | Degenerative Lumbar Spinal StenosisItaly
-
University Hospital, Basel, SwitzerlandKlinik für Radiologie und Nuklearmedizin, University Hospital BaselCompletedLumbar Spinal Stenosis | Symptomatic Lumbar Spinal StenosisSwitzerland
-
Sklifosovsky Institute of Emergency CarePirogov National Medical Surgical Center; Federal State Budgetary Institution... and other collaboratorsActive, not recruitingLumbar Spinal Stenosis | Spinal Stenosis | Spinal FusionRussian Federation
-
Region ZealandRegion SyddanmarkRecruiting
-
Tang-Du HospitalNot yet recruiting
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedLumbar Spinal StenosisTurkey
Clinical Trials on 0.9% Sodium Chloride Injection
-
Livzon Pharmaceutical Group Inc.UnknownCarcinogenic FatigueChina
-
Beijing Tiantan HospitalNot yet recruitingEdema Brain
-
Jeffrey Alan Klein, MDNot yet recruitingAnesthesia, Local | Injection Site Irritation | Injection Site Discomfort | Injection Site Bruising | Benzoic Acid Adverse ReactionUnited States
-
Caliway Biopharmaceuticals Co., Ltd.Not yet recruiting
-
Green Valley Group of ChinaUnknown
-
Causeway TherapeuticsRecruiting
-
Spero TherapeuticsClinical Network Services (CNS) Pty LtdCompletedHealthy VolunteersAustralia
-
Southeast University, ChinaUnknown